Public Health Agency of Canada COVID-19 virtual library of health data and evidence
Public Health Agency of Canada's COVID-19 mask use advice for community settings has been updated to include the following:
- Even if masks are not required in an individual’s region or the setting they are in, and whether they are vaccinated or not, wearing a mask is an added layer of protection.
- Masks are strongly recommended in any crowded setting, including settings with vaccination requirements.
- Individuals should consider how they could improve the fit of their masks by adjusting features like ties, ear loops, flexible nosepieces, mask fitters or braces. Choosing a mask with ties or bands that go around the back of the head may help provide a better fit.
- While non-medical masks help prevent the spread of COVID-19, medical masks and respirators provide better protection. A medical mask is recommended for some groups and settings, including:
- anyone who has tested positive or has symptoms of COVID-19;
- people caring for someone who has tested positive or has symptoms of COVID-19,
- people living in overcrowded settings with someone who has tested positive or has symptoms of COVID-19;
- people who are at risk of more severe disease or outcomes from COVID-19; and
- people who are at a higher risk of exposure to COVID-19 because of their living situation.
COVID-19: Epidemiology, virology, and prevention: UpToDate Coronavirus Topic
COVID-19 signs, symptoms and severity of disease: A clinician guide
Coronavirus disease (COVID-19): For health professionals
CSHP's COVID-19 Patient Discharge Tips
Vaccine storage, handling, and rollout
Vaccine Induced Immune Thrombotic Thrombocytopenia (VITT)
National Advisory Committee on Immunization (NACI) Recommendations
Health Canada Recommendations
Critical care and medical emergencies
COVID-19 Pharmacy Specialty Network
In an effort to share information and best hospital pharmacy practices regarding COVID-19, the Canadian Society of Hospital Pharmacists has set-up a special open access (free to members and non-members) Pharmacy Specialty Network (PSN). Join the COVID-19 PSN here.
International Networking Resources
ASHP COVID-19 Connect Community: American Society of Health-System Pharmacists
Also on this page
See CSHP's full statement on COVID-19 here
Care for patients is at the heart of the hospital pharmacy profession. During the pandemic, you put yourself at even higher risk than you normally experience in the course of your work. We acknowledge the dedication and professionalism that underscores your service to public health. We also see your humanity and the vulnerability inherent in that service and are here to support you through this journey.
~Tania Mysak, BSP, PharmD, CSHP President; Jody Ciufo, MBA, CSHP CEO
Additional Member Updates
COVID-19: Coping and Resilience for Pharmacy Professionals
Novel Coronavirus: COVID-19 vaccines
PM and PSWs: The Ottawa Hospital experience with the Pfizer COVID-19 vaccine
COVID–19 treatment updates
COVID–19 in the US: the perspective of pharmacists on policy and practice
Preparing for a Second COVID Wave: Personal and Departmental Considerations
Disease in the Body of COVID-19 Related Scientific Literature: Fabrication, Falsification or Fallacy
Drug Shortages During the COVID-19 Pandemic: Conservation Strategies and Therapeutic Alternatives
Pharmacy Student Experiences During COVID-19 Pandemic
Care of Older Adults During the COVID-19 Pandemic: Reflections and Strategies for Medication and Patient Safety
Remdesivir — What's with all the noise?
Our Experience with Virtual Care – Perspectives from the Pharmacists Clinic
Pharmacy Involvement at a Long-Term Care Home
Medications at the End-of-Life: Palliative Care Pharmacotherapy for the Dying Patient - Part 2
Medications at the End-of-Life: Palliative Care Pharmacotherapy for the Dying Patient - Part 1
The Role of Team-Based Primary-Care Pharmacists During a Pandemic
Panel: Pharmacy Residents' Experiences During a Pandemic
Prescribing the Right Course of Action: Pharmacy Ethics in a Pandemic
COVID-19: What Employees Need from Leadership
Field Hospitals: A Royal Canadian Medical Service Perspective
Ventilators are only good if you have the medications to use them: understanding drug supply during COVID-19
Conserving Drugs with Sterile Compounding During the COVID-19 Pandemic
Pediatric COVID-19 Treatment Considerations
ICU 101 for Pharmacists - Crash Course in Critical Care — Part 2
ICU 101 for Pharmacists - Crash Course in Critical Care — Part 1
What are the Treatment Options for COVID-19? (Panel Discussion)
Adapting Hospital Pharmacy Practice During a Pandemic
Evaluating Evidence for Emerging Therapies During a Pandemic
COVID19: Managing Autoimmune, Psychiatric and Trauma Responses
Implementing Hospital Telepharmacy: Review of CSHP’s Telepharmacy Guidelines
Going Nsane over NSAIDs: Evaluation of the evidence behind the rejection of ibuprofen in management of COVID-19
Canadian Journal of Hospital Pharmacy
Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?
CSHP-BC COVID-19 What Pharmacists Know Now: Free Short Video Series
|COVID-19: What Pharmacists Know Now: Coagulopathy in COVID-19
Presented by Celia Culley
BSP, ACPR, PharmD
|May 5, 2020
|COVID-19 and Cancer Patients
Presented by Sally Waigenein BSc(Pharm), PharmD, ACPR
|April 20, 2020
I am Pregnant or Breastfeeding – What Should I do?
Presented by Hilary Rowe BSc(Pharm), PharmD, ACPR
View recording (18 minutes)
|April 14, 2020
|Injecting Knowledge – a COVID-19 Vaccine Update
|Presented by Jillian Reardon, BSc(Pharm), PharmD, ACPR
View recording (14 minutes)
|April 6, 2020
|Role of Statins
|Presented by Ricky Turgeon, BSc(Pharm), ACPR, PharmD
View recording (14 minutes)
|April 3, 2020
|COVID-19 Virus Stability and Transmission
|Presented by Kelly Grindrod, BScPh(arm), PharmD, MSc
|March 30, 2020
|Should we avoid corticosteroids?
||Presented by Megan Harbin, BSc(Pharm), PharmD, ACPR
|March 27, 2020
Role of Hydroxychloroquine
|Presented by Gregory Mah, PharmD
|March 27, 2020
|Should patients discontinue their ACE inhibitors and ARBs?
||Presented by Arden Berry, BSc, BSc(Pharm), PharmD, ACPR
|March 25, 2020
|Does ibuprofen worsen COVID-19 Infection?
||Presented by Doson Chua, BSc(Pharm), PharmD, FCSHP, BCPS, BCCP
|March 24, 2020
CSHP in the News
CMAJ — Temporary fixes to chronic drug shortages leave Canada vulnerable
CBC Second Opinion - Safety Prioritized
CBC-Metro Morning - Implications for workers left off of Ontario's "pandemic pay"
Winnipeg Free Press - Drug shortages push federal government to seek new suppliers
CTV News - COVID-19 exposes drug supply gaps as 'made in Canada' solution proposed
CTV News - Forgotten Healthcare Workers Not on list for Ontario's $4 per hour wage increase
Globe and Mail — Doctors brace for shortages of sedation drugs needed for surgeries, intubation
We have partnered with all major pharmacy sector stakeholders to advocate on a number of fronts with several government agencies. In addition to contributing to pandemic response teams at various levels, CSHP signed on to an open letter to the Government of Canada , led by CPhA and co-signed by 16 other national and provincial organizations, that calls for Health Canada to recognize pharmacists as essential healthcare providers, with respect to the supply and allocation of PPE. CSHP is working with CPhA to craft evidence-based PPE best-practice recommendations.
CSHP members – pharmacists, pharmacy technicians, pharmacy students, interns and residents – insured with our preferred provider BMS are in good hands. Please review the COVID-19: Insurance Coverage Position Statement for details. A note for our retired members: If you return to work, you must purchase an active policy (and should check with your provincial regulatory body about registration to active status). Pro-rated fees are available for shorter terms between now and June 30, 2020. Learn more here .
A complete .pdf copy of CSHP member, Dr. Joel Lamoure's letter can be accessed here .
In a period of personal and professional uncertainty, and a seemingly endless wave of scary recent information, I wish to add a few thoughts and validations for my colleagues. I am speaking from 30 years of pharmacy including neurosurgical ICU, psychiatry practice and serving as the UNESCO Canadian Section Chief for medical bioethics. The number one paper that people accessed from my publications around the world this week was about Management of Panic Disorder, so I think it is time for me to weigh in.
~Joel Lamoure RPh., DD., FASCP
Use #COVID19RX for treatments related to COVID-19